The paper deal with a case of patient with genotype poor metaboliser CYP2D6 and severe adverse effects with polypharmacotherapy with CYP2D6 substrates and inhibitors.
The paper deal with a case of patient with genotype poor metaboliser CYP2D6 and severe adverse effects with polypharmacotherapy with CYP2D6 substrates and inhibitors. (en)
Jde o kazusitku pacienta s četnými komplikacemi léčby při polyfarmakoterapii a polymorbiditě při zjištěném pomalém metabolickém fenotypu (cs)